HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.

AbstractRATIONALE:
Recent studies have shown that metabotropic glutamate receptor 5 (mGluR5) can modulate N-methyl-D-aspartate receptor function. Our previous findings demonstrated that the selective mGluR5 agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) and the antagonist 2-methyl-6-(phenylethynyl)-pyridine can reduce and enhance the ketamine anesthesia, respectively.
OBJECTIVE:
The purpose of this study was to examine whether CHPG and positive allosteric modulator 3,3'-difluorobenzaldazine (DFB) can reverse ketamine-induced behavioral responses including locomotor hyperactivity, motor incoordination, sensorimotor gating deficit, and learning impairment.
METHODS:
Mice were pretreated with CHPG (5-50 nmol,) or DFB (40-100 nmol) followed by ketamine administration. Locomotor activity, rotarod test, prepulse inhibition (PPI) of acoustic startle test, and novel object recognition test were examined.
RESULTS:
CHPG and DFB had no effect on these behaviors when administered alone. Both of them attenuated the locomotor hyperactivity, motor incoordination, and cognitive impairment induced by ketamine. However, the ketamine-induced PPI deficit was reversed by CHPG (50 nmol) but not by DFB (up to 100 nmol). CHPG and DFB have distinct potency and efficacy in attenuating ketamine-induced behavioral response.
CONCLUSIONS:
These behavioral data extend previous findings and further suggest that positive modulation of mGluR5 may provide a novel approach for development of antipsychotic agents.
AuthorsMing-Huan Chan, Pao-Hsiang Chiu, Jen-Hou Sou, Hwei-Hsien Chen
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 198 Issue 1 Pg. 141-8 (May 2008) ISSN: 0033-3158 [Print] Germany
PMID18311557 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-chloro-5-hydroxyphenylglycine
  • 3,3'-difluorobenzaldazine
  • Excitatory Amino Acid Antagonists
  • Grm5 protein, mouse
  • Hydrazines
  • Phenylacetates
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate
  • Ketamine
  • Glycine
Topics
  • Animals
  • Behavior, Animal (drug effects)
  • Cognition Disorders (chemically induced, drug therapy, psychology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glycine (analogs & derivatives, pharmacology)
  • Hydrazines (pharmacology)
  • Injections, Intraventricular
  • Ketamine (pharmacology)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Motor Activity (drug effects)
  • Phenylacetates (pharmacology)
  • Postural Balance (drug effects)
  • Psychomotor Performance (drug effects)
  • Receptor, Metabotropic Glutamate 5
  • Receptors, Metabotropic Glutamate (drug effects)
  • Recognition, Psychology (drug effects)
  • Reflex, Startle (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: